cardiovascular-disease

Documents about cardiovascular-disease

• Characteristics of Cardiovascular Disease Prediction Models Considering Mental Disorders: A Systematic Review.#326868NCBI PubMed Central
• Cost-effectiveness of a statewide public health intervention to reduce cardiovascular disease risk#372621Semantic Scholar
• Pre-existing Cardiovascular Disease and Periodontitis: A Follow-up Study#384158CiNii
• How do counties' industrial structures shape geographic disparities in cardiovascular disease mortality?#446276NCBI PubMed Central
• Heart Failure in the Community#448191ClinicalTrials.gov
• Maternal circadian disruption during pregnancy and offspring diabetic cardiovascular disease risk.#653459NCBI PubMed Central
• Almond Dose Response Study.#829570ClinicalTrials.gov
• pCAD-POAF 3 Year Follow-up#834412ClinicalTrials.gov
• Implementation of Practice Standards for ECG Monitoring#837495ClinicalTrials.gov
• Lifestyle Modification and Blood Pressure Study#849655ClinicalTrials.gov
• Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular Disease#836398ClinicalTrials.gov
• Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization#6901OpenAlex
• Lifestyle and Chronic Disease in College Alumni (Harvard Alumni Health Study)#363506ClinicalTrials.gov
• National Health and Nutrition Examination Survey IV (NHANES (IV)#373692ClinicalTrials.gov
• Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort- evaluation of risk factors and their interactions#383773CiNii
• Feasibility of The Health Integrated Nutrition and Kidney Wellness Program#806291ClinicalTrials.gov
• European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)#6157OpenAlex
• Comparative Effectiveness of Tirzepatide Versus Dulaglutide or Semaglutide on Major Cardiovascular Events in Type 2 Diabetes and Cardiovascular Disease: Insights From Two Target-Trial Emulations.#266912NCBI PubMed Central
• Homocysteine and other markers of cardiovascular risk during a manic episode in patients with bipolar disorder#284711Lume 5.8
• Motivational Interviewing and Cognitive Behavioral Therapy-based Intervention for Cardiovascular Disease Prevention Amongst American Indians With Diabetic and Depressive Symptoms#366515ClinicalTrials.gov
• Climate change and cardiovascular risk factors management: emerging challenges and strategies for prevention and adaptation.#423309PubMed
• Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses#805592ClinicalTrials.gov
• Emotion Regulation Training to Reduce Cardiovascular Disease Risk Among Depressed Young Adults in Southern Mississippi#838421ClinicalTrials.gov
• SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System#803657ClinicalTrials.gov
• ARISTOCRAT-A Randomized Controlled Trial Evaluating Closure Following Access With the AXERA (Device Name) 2 Access System#838665ClinicalTrials.gov
• Repository of Phase Signals for Pulmonary Hypertension Algorithm Development#123611ClinicalTrials.gov
• Cardiovascular Disease Education and Problem-Solving Training in People With Type 2 Diabetes#226177ClinicalTrials.gov
• Artificial intelligence clinical decision support systems for cardiovascular magnetic resonance imaging in aortic valve disease#251983Spiral
• Understanding Local Determinants of Cardiovascular Disease and Diabetes#272458ClinicalTrials.gov
• Effectiveness of Sitagliptin for HIV Insulin Resistance and Inflammation#307383ClinicalTrials.gov
• Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality#383811CiNii
• Association of Smoking Cannabis With Cardiovascular Events Among Veterans With Coronary Artery Disease.#388811NCBI PubMed Central
• The Effect of an Alginate Based Beverage on Weight Loss#398243ClinicalTrials.gov
• Metabolic Health: The Interplay Between NAFLD, MAFLD, MASLD, and Cardiovascular Disease.#409239NCBI PubMed Central
• Study of Children's Activity and Nutrition (SCAN)#426670ClinicalTrials.gov
• HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)#438560ClinicalTrials.gov
• Transient Apical Sparing in Hypertensive Heart Disease Explained by Laplace's Law#459881bioRxiv / medRxiv
• Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus#463660ClinicalTrials.gov
• Distortion of the terminal QRS complex in patients with ST-elevation myocardial infarction#659415Lund University Publications
• Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study#805623ClinicalTrials.gov
• Supporting Post Myocardial Infarction (MI) Risk Modification Intervention Via Telemedicine Evaluation#806176ClinicalTrials.gov
• A Post Market Study on the Use of Cormatrix® Cangaroo ECM® (Extracellular Matrix) Envelope#808042ClinicalTrials.gov
• 7 Year Follow-up Study of the DanRisk Population#837568ClinicalTrials.gov
• Hispanic Community Health Study / Study of Latinos#839765ClinicalTrials.gov
• Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke#846252ClinicalTrials.gov
• Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019#6917OpenAlex
• Risk Factors for Cardiovascular Disease in Community-Dwelling Older Adults: The Potential Role of Dual Screening for Chronic Kidney Disease and Sarcopenia#143868bioRxiv / medRxiv
• Optimizing Behavioral Health Homes for Adults With Serious Mental Illness#287408ClinicalTrials.gov
• Prevalence of coronary heart disease risk factors in physical education students#345479Repositório Institucional da Universidade Federal de Sergipe
• Meta-organismal tryptophan metabolism: an appealing therapeutic target in CKD-MBD#476031HAL (France)